Country: South Africa
Language: English
Source: South African Health Products Regulatory Authority (SAHPRA)
Aspen-p
AVOMINE® TABLETS SCHEDULING STATUS: S2 PROPRIETARY NAME (and dosage form): AVOMINE ® TABLETS COMPOSITION: Tablets each containing: Promethazine Theoclate 25 mg PHARMACOLOGICAL CLASSIFICATION: A 5.7.2 Anti-emetics and antivertigo preparations. PHARMACOLOGICAL ACTION: AVOMINE is an active, well tolerated, anti-emetic for use in the prevention and treatment of travel sickness. INDICATIONS: AVOMINE gives highly successful results in the prevention and treatment of seasickness, car-sickness, train-sickness and air-sickness; it may be used routinely for prevention and also for the treatment of established cases. CONTRA-INDICATIONS: This product should not be used in children under 2 years of age because the safety of such use has not been established. Safety in pregnancy and lactation has not been established. WARNINGS: The use of this medicine may lead to drowsiness and impaired concentration which may be aggravated by the simultaneous intake of alcohol or other central nervous system depressant agents. Patients should be warned against taking charge of vehicles or machinery or performing potentially hazardous tasks where loss of concentration may lead to accidents. DOSAGE AND DIRECTIONS FOR USE: ADULTS For Prevention (a) Long journeys: one tablet each night at bedtime commencing on the night before travelling. (b) Short journeys: one tablet to be taken 1 - 2 hours before the journey commences. For Treatment One tablet, followed by a second tablet the same evening and a third tablet on the following evening. Prompt treatment is important. Additional tablets may safely be taken for prophylaxis or when they appear to be needed but it will seldom be necessary to give more than four tablets in 24 hours or to repeat a dose in less than 8 hours. CHILDREN: 5 - 10 years: one half the Read the complete document